Cesar Peres Dulac Müller logo

CPDMA BLOG

Category:
Date: October 15, 2019
Posted by: CPDMA Team

STJ major increases from R$ 15 thousand to more than R$ 1 million succumbence in bankruptcy filing

3ª turma fixou verba com base em regra geral do CPC/15. 

A 3ª turma do STJ proveu recurso para fazer incidir a regra geral do § 2º do art. 85 do CPC/15 na fixação de sucumbência, que prevê verba entre 10 e 20%, em detrimento do §8º, de apreciação equitativa.

No caso, foi extinto pelo juízo de 1º grua pedido de falência contra empresa por suposta impontualidade no pagamento de duplicata de prestação de serviços, cujo crédito era de R$ 10,9 milhões.

O magistrado fixou a verba honorária sucumbencial em 10% do valor da causa, nos termos do § 2º, do art. 85, do CPC. Já em 2º grau, a Corte de origem redimensionou o valor dos honorários, fixando-os em R$ 15 mil.

O ministro Ricardo Cueva, relator, ao analisar o recurso, recordou que a 2ª seção do STJ definiu que o § 2º do art. 85 do CPC/15 constitui a regra geral no sentido de que os honorários sucumbenciais devem fixados no patamar de 10% a 20% sobre o valor da condenação, do proveito econômico obtido ou do valor atualizado da causa – e que a previsão do § 8º é norma de caráter excepcional, de aplicação subsidiária.

“Não se desconsidera que a fixação ora determinada resultará em quantia bastante elevada a título de honorários advocatícios, tendo em vista que o valor dado à causa pela autora, ora recorrida, foi de R$ 10.938.837,58 (dez milhões, novecentos e trinta e oito mil oitocentos e trinta e sete reais e cinquenta centavos), em fevereiro de 2016. Contudo, uma vez decidida a questão pela Segunda Seção, não há outra solução possível para o caso em exame, mormente se considerada a função constitucional precípua desta Corte Superior de uniformização do direito infraconstitucional.”

Assim, Cueva proveu o recurso, restabelecendo a sentença no tocante à sucumbência. O colegiado acompanhou o entendimento do relator.

Source: Migalhas Portal.

Return

Recent posts

Discover the asset class - INDUSTRIAL DESIGN

In our series of posts explaining the differences between classes of intellectual assets, today we're going to look at INDUSTRIAL DESIGN. Industrial Design is the ornamental plastic form of an object - for example, the design of a product or the set of lines applied to a product, such as a print - that gives it [...]

Read more
Learn about the asset class - PATENTS

A PATENT is a title of ownership granted by the State over an unpublished invention (invention patent) or one derived from an existing one (utility model patent). The application for registration is made to the INPI, granting the holder the right to prevent third parties from manufacturing, using or offering for sale [...].

Read more
Corporate name: get to know this asset class

Continuing with our series of posts explaining the differences between the classes of intellectual assets, today we'll look at the BUSINESS NAME. Although trademarks - the nature of which has already been described in the previous post - can sometimes be confused with business names, they are distinct legal institutes. The business name identifies the company by [...]

Read more
PERSE: legislative changes in the emergency program to revive the events sector

Law No. 14,859/2024: amendment of the Perse rules for the period 2024 to 2026. The Emergency Program for the Resumption of the Events Sector - Perse was created in 2021 with a view to helping companies linked to the events sector - the activity most affected by the COVID-19 pandemic, by reducing [...]

Read more
The extent of insurance cover in floods

The rains that have hit Rio Grande do Sul in recent weeks have destroyed farms, properties and vehicles. Even if they have insurance, car or property owners should check the coverage of their policies to see if they can get compensation. Basic insurance for cars and properties does not usually cover floods. Insurance against electrical breakdown, [...]

Read more
The agreement to sell the most famous slimming drug of the moment

It was recently reported that the Brazilian company BIOMM has signed an agreement with the pharmaceutical industry BIOCON to distribute in Brazil a drug similar to Ozempic, indicated for the treatment of diabetes, but used mainly to treat obesity. However, this will only be possible because the patent holder of the drug has certainly authorized, through a [...]

Read more
crossmenuchevron-down
en_USEnglish
linkedin Facebook pinterest youtube lol twitter Instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter Instagram